Document is current
Any future updates will be listed below
-
Authors
Shafie, Asrul Akmal https://orcid.org/0000-0002-5629-9270
Mohammed, Noor Syahireen https://orcid.org/0000-0002-5279-088X
See, Kok Fong https://orcid.org/0000-0002-3536-7131
Ibrahim, Hishamshah Mohd https://orcid.org/0000-0002-0689-3095
Wong, Jacqueline Hui Yi https://orcid.org/0000-0003-0447-5786
Chhabra, Irwinder Kaur https://orcid.org/0000-0003-2153-7520
-
Funding
Funding for this research was provided by:
Novartis Pharma
- License Information
-
More Information
Article History
Received: 10 March 2020
Accepted: 20 December 2021
First Online: 26 January 2022
Declarations
:
: This study was registered with the Malaysian National Medical Research Registry (NMRR-17-2614-38,966(ISR)) and approved by the Malaysia Medical Research and Ethics Review Committee.
: Not applicable.
: AAS and HMI were appointed by Novartis for speaking engagement. The remaining authors declare no conflict of interests.
